Concepts (382)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Drug | 37 | 2005 | 61 | 5.200 |
Why?
|
| Blood Platelets | 26 | 2006 | 81 | 2.590 |
Why?
|
| Agmatine | 14 | 2013 | 17 | 2.040 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 18 | 2003 | 39 | 1.860 |
Why?
|
| Clonidine | 25 | 2005 | 50 | 1.820 |
Why?
|
| Depressive Disorder | 19 | 2006 | 187 | 1.770 |
Why?
|
| Imidazoline Receptors | 40 | 2006 | 41 | 1.650 |
Why?
|
| Neuroblastoma | 2 | 2022 | 136 | 1.340 |
Why?
|
| Imidazoles | 17 | 2005 | 142 | 1.330 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 9 | 2005 | 200 | 1.130 |
Why?
|
| Carrier Proteins | 9 | 2003 | 321 | 1.040 |
Why?
|
| Probiotics | 1 | 2022 | 37 | 0.730 |
Why?
|
| Brain | 12 | 2004 | 1472 | 0.720 |
Why?
|
| Brassica | 1 | 2021 | 16 | 0.680 |
Why?
|
| Coculture Techniques | 1 | 2021 | 109 | 0.670 |
Why?
|
| Adrenergic alpha-Agonists | 9 | 2003 | 32 | 0.620 |
Why?
|
| Radioligand Assay | 18 | 2006 | 65 | 0.610 |
Why?
|
| Ureohydrolases | 2 | 2013 | 3 | 0.600 |
Why?
|
| Guanidines | 2 | 2013 | 17 | 0.600 |
Why?
|
| Brain Chemistry | 4 | 2003 | 141 | 0.580 |
Why?
|
| Receptors, Adrenergic, alpha | 8 | 1991 | 17 | 0.560 |
Why?
|
| Bupropion | 4 | 2002 | 13 | 0.540 |
Why?
|
| Antidepressive Agents, Second-Generation | 3 | 2009 | 6 | 0.520 |
Why?
|
| Neuroprotective Agents | 3 | 2013 | 269 | 0.520 |
Why?
|
| Animals | 50 | 2020 | 16992 | 0.480 |
Why?
|
| Antihypertensive Agents | 4 | 2005 | 287 | 0.450 |
Why?
|
| Desipramine | 7 | 2006 | 13 | 0.440 |
Why?
|
| Rats | 21 | 2020 | 3735 | 0.440 |
Why?
|
| Humans | 62 | 2022 | 43102 | 0.430 |
Why?
|
| Methoxyhydroxyphenylglycol | 5 | 1998 | 17 | 0.430 |
Why?
|
| Bipolar Disorder | 3 | 2011 | 84 | 0.420 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2013 | 44 | 0.420 |
Why?
|
| Binding Sites | 15 | 2003 | 671 | 0.410 |
Why?
|
| Down-Regulation | 7 | 2009 | 456 | 0.370 |
Why?
|
| Yohimbine | 7 | 2000 | 24 | 0.370 |
Why?
|
| Drug Discovery | 1 | 2013 | 108 | 0.370 |
Why?
|
| Piperazines | 1 | 2013 | 120 | 0.370 |
Why?
|
| Iodine Radioisotopes | 8 | 2003 | 38 | 0.360 |
Why?
|
| Adrenergic alpha-Antagonists | 5 | 2003 | 29 | 0.340 |
Why?
|
| Databases, Genetic | 1 | 2011 | 103 | 0.330 |
Why?
|
| Male | 38 | 2009 | 23409 | 0.320 |
Why?
|
| Antidepressive Agents | 3 | 2000 | 65 | 0.320 |
Why?
|
| Metallothionein | 8 | 1987 | 20 | 0.300 |
Why?
|
| Adult | 27 | 2009 | 13872 | 0.300 |
Why?
|
| Norepinephrine | 8 | 2006 | 97 | 0.300 |
Why?
|
| Proteins | 4 | 2003 | 382 | 0.300 |
Why?
|
| Cyclohexanols | 1 | 2009 | 11 | 0.300 |
Why?
|
| Epinephrine | 6 | 2003 | 36 | 0.290 |
Why?
|
| Imipramine | 3 | 1997 | 9 | 0.290 |
Why?
|
| Reference Values | 8 | 2009 | 211 | 0.290 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 140 | 0.270 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2013 | 1766 | 0.260 |
Why?
|
| Middle Aged | 22 | 2009 | 12222 | 0.260 |
Why?
|
| Female | 38 | 2009 | 24698 | 0.260 |
Why?
|
| Nitric Oxide Synthase | 3 | 2005 | 135 | 0.260 |
Why?
|
| Blood Pressure | 3 | 2003 | 666 | 0.260 |
Why?
|
| Protein Isoforms | 2 | 2003 | 139 | 0.250 |
Why?
|
| Amino Acid Motifs | 2 | 2003 | 97 | 0.240 |
Why?
|
| DNA, Complementary | 5 | 2004 | 196 | 0.240 |
Why?
|
| Zinc | 6 | 1987 | 131 | 0.240 |
Why?
|
| Medulla Oblongata | 3 | 2005 | 42 | 0.240 |
Why?
|
| RNA, Messenger | 6 | 2003 | 1271 | 0.230 |
Why?
|
| Liver | 9 | 1999 | 511 | 0.230 |
Why?
|
| Depression | 5 | 2003 | 863 | 0.220 |
Why?
|
| Metalloproteins | 6 | 1983 | 25 | 0.220 |
Why?
|
| Platelet Activation | 2 | 2003 | 6 | 0.220 |
Why?
|
| Monoamine Oxidase | 2 | 2006 | 37 | 0.220 |
Why?
|
| Platelet Count | 2 | 2006 | 13 | 0.220 |
Why?
|
| Harmine | 1 | 2003 | 4 | 0.210 |
Why?
|
| Gene Expression Regulation | 2 | 2006 | 1070 | 0.210 |
Why?
|
| Caudate Nucleus | 1 | 2003 | 22 | 0.210 |
Why?
|
| Hippocampus | 2 | 2013 | 594 | 0.200 |
Why?
|
| Psychiatry | 1 | 2003 | 36 | 0.200 |
Why?
|
| Frontal Lobe | 1 | 2003 | 58 | 0.200 |
Why?
|
| Alternative Splicing | 1 | 2003 | 94 | 0.200 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2006 | 15 | 0.190 |
Why?
|
| Animals, Newborn | 5 | 2013 | 352 | 0.190 |
Why?
|
| Exploratory Behavior | 1 | 2003 | 78 | 0.190 |
Why?
|
| Cell Communication | 1 | 2003 | 114 | 0.190 |
Why?
|
| Lactobacillus | 1 | 2022 | 22 | 0.190 |
Why?
|
| Amygdala | 1 | 2003 | 125 | 0.190 |
Why?
|
| Immune Sera | 5 | 2000 | 56 | 0.190 |
Why?
|
| Blood-Brain Barrier | 1 | 2003 | 173 | 0.180 |
Why?
|
| Glycols | 3 | 1990 | 8 | 0.180 |
Why?
|
| Tritium | 8 | 2000 | 46 | 0.180 |
Why?
|
| Up-Regulation | 4 | 1998 | 536 | 0.180 |
Why?
|
| Neurons | 4 | 2003 | 1263 | 0.180 |
Why?
|
| Membrane Fluidity | 2 | 1991 | 10 | 0.180 |
Why?
|
| Astrocytes | 1 | 2003 | 244 | 0.180 |
Why?
|
| Mice, Mutant Strains | 3 | 1987 | 83 | 0.180 |
Why?
|
| Circadian Rhythm | 3 | 1994 | 236 | 0.170 |
Why?
|
| Taraxacum | 1 | 2021 | 2 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 386 | 0.170 |
Why?
|
| Spinacia oleracea | 1 | 2021 | 8 | 0.170 |
Why?
|
| Menstrual Cycle | 2 | 1998 | 36 | 0.170 |
Why?
|
| Electric Impedance | 1 | 2021 | 28 | 0.170 |
Why?
|
| P-Selectin | 1 | 2000 | 8 | 0.170 |
Why?
|
| Caco-2 Cells | 1 | 2021 | 64 | 0.170 |
Why?
|
| Epithelium | 1 | 2021 | 78 | 0.170 |
Why?
|
| Oxidopamine | 2 | 2005 | 23 | 0.170 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2000 | 42 | 0.170 |
Why?
|
| Signal Transduction | 3 | 2013 | 2157 | 0.160 |
Why?
|
| Tetracycline | 1 | 2020 | 17 | 0.160 |
Why?
|
| Biological Availability | 1 | 2021 | 116 | 0.160 |
Why?
|
| Peptides | 1 | 2003 | 372 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2009 | 1124 | 0.160 |
Why?
|
| Postmenopause | 1 | 2000 | 141 | 0.160 |
Why?
|
| Carboxy-Lyases | 3 | 2004 | 4 | 0.160 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2002 | 282 | 0.150 |
Why?
|
| Feces | 1 | 2020 | 132 | 0.150 |
Why?
|
| Integrins | 3 | 2003 | 54 | 0.150 |
Why?
|
| Cholinergic Antagonists | 1 | 1999 | 10 | 0.150 |
Why?
|
| Cerebral Ventricles | 1 | 1999 | 23 | 0.150 |
Why?
|
| Macrophages | 1 | 2003 | 529 | 0.150 |
Why?
|
| Cell Membrane | 8 | 1997 | 403 | 0.150 |
Why?
|
| Dystonia | 1 | 1999 | 12 | 0.150 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2021 | 134 | 0.150 |
Why?
|
| Enzyme Inhibitors | 4 | 2013 | 458 | 0.150 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 1999 | 83 | 0.140 |
Why?
|
| Milk | 4 | 1987 | 56 | 0.140 |
Why?
|
| Antipsychotic Agents | 1 | 1999 | 80 | 0.140 |
Why?
|
| Mice | 13 | 2003 | 6644 | 0.140 |
Why?
|
| Posture | 2 | 1997 | 61 | 0.140 |
Why?
|
| Binding, Competitive | 6 | 1999 | 109 | 0.140 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 1998 | 13 | 0.140 |
Why?
|
| CHO Cells | 4 | 2005 | 123 | 0.140 |
Why?
|
| Idazoxan | 4 | 2000 | 10 | 0.130 |
Why?
|
| Cricetinae | 4 | 2005 | 241 | 0.130 |
Why?
|
| Treatment Outcome | 4 | 2009 | 1604 | 0.130 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 2676 | 0.130 |
Why?
|
| Aged, 80 and over | 6 | 2003 | 2853 | 0.130 |
Why?
|
| Stress, Psychological | 1 | 2003 | 661 | 0.130 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1997 | 8 | 0.130 |
Why?
|
| Orientation | 1 | 1997 | 33 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 508 | 0.130 |
Why?
|
| Blotting, Western | 5 | 2006 | 883 | 0.130 |
Why?
|
| Postural Balance | 1 | 1997 | 37 | 0.130 |
Why?
|
| Brain Stem | 1 | 1997 | 52 | 0.130 |
Why?
|
| PC12 Cells | 5 | 2003 | 93 | 0.120 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 1996 | 4 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 432 | 0.120 |
Why?
|
| Fluoxetine | 1 | 1996 | 15 | 0.120 |
Why?
|
| Time Factors | 4 | 2006 | 1857 | 0.120 |
Why?
|
| Amino Acid Sequence | 4 | 2004 | 1180 | 0.120 |
Why?
|
| Molecular Sequence Data | 4 | 2004 | 1542 | 0.110 |
Why?
|
| Aged | 8 | 2003 | 8214 | 0.110 |
Why?
|
| Hypotension | 2 | 2005 | 24 | 0.100 |
Why?
|
| Platelet Aggregation | 1 | 1993 | 21 | 0.100 |
Why?
|
| Affinity Labels | 3 | 2000 | 7 | 0.100 |
Why?
|
| Lactation | 3 | 1987 | 44 | 0.100 |
Why?
|
| Statistics as Topic | 2 | 2003 | 123 | 0.100 |
Why?
|
| Rabbits | 3 | 2005 | 278 | 0.100 |
Why?
|
| Personality Inventory | 2 | 2009 | 82 | 0.100 |
Why?
|
| Milk Proteins | 3 | 1981 | 29 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2013 | 83 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2013 | 121 | 0.100 |
Why?
|
| Organ Culture Techniques | 1 | 2013 | 101 | 0.100 |
Why?
|
| Anxiety Disorders | 1 | 1996 | 322 | 0.100 |
Why?
|
| Tissue Distribution | 1 | 2013 | 240 | 0.100 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 280 | 0.090 |
Why?
|
| Intracellular Membranes | 1 | 1991 | 36 | 0.090 |
Why?
|
| Cloning, Molecular | 4 | 2004 | 314 | 0.090 |
Why?
|
| Cell Line | 3 | 2003 | 1410 | 0.090 |
Why?
|
| Neurotoxins | 2 | 2003 | 57 | 0.090 |
Why?
|
| GTP-Binding Proteins | 3 | 1996 | 59 | 0.090 |
Why?
|
| Suicide | 2 | 2003 | 140 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2005 | 465 | 0.080 |
Why?
|
| Chromatography, Gas | 1 | 1989 | 15 | 0.080 |
Why?
|
| COS Cells | 4 | 2004 | 68 | 0.080 |
Why?
|
| Molecular Weight | 3 | 2003 | 168 | 0.080 |
Why?
|
| Animals, Suckling | 2 | 1987 | 13 | 0.080 |
Why?
|
| Immunoblotting | 3 | 2003 | 181 | 0.070 |
Why?
|
| Naphazoline | 2 | 2000 | 2 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 423 | 0.070 |
Why?
|
| Organ Specificity | 2 | 1999 | 141 | 0.070 |
Why?
|
| Neurotransmitter Agents | 2 | 2003 | 69 | 0.070 |
Why?
|
| Cattle | 4 | 1998 | 498 | 0.070 |
Why?
|
| Transfection | 4 | 2004 | 532 | 0.070 |
Why?
|
| Copper | 2 | 1987 | 134 | 0.070 |
Why?
|
| Dizocilpine Maleate | 2 | 2005 | 43 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2003 | 1869 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 734 | 0.070 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2006 | 7 | 0.060 |
Why?
|
| Psychotropic Drugs | 1 | 1986 | 18 | 0.060 |
Why?
|
| Subcellular Fractions | 2 | 2003 | 77 | 0.060 |
Why?
|
| Mice, Inbred C3H | 2 | 1983 | 80 | 0.060 |
Why?
|
| Ganglionic Stimulants | 1 | 2006 | 2 | 0.060 |
Why?
|
| Tobacco, Smokeless | 1 | 2006 | 19 | 0.060 |
Why?
|
| Locus Coeruleus | 1 | 2006 | 17 | 0.060 |
Why?
|
| Autoradiography | 2 | 2003 | 37 | 0.060 |
Why?
|
| Receptors, Adrenergic | 1 | 1985 | 10 | 0.060 |
Why?
|
| Morphine | 1 | 2005 | 69 | 0.060 |
Why?
|
| Mice, Inbred Strains | 2 | 1981 | 114 | 0.060 |
Why?
|
| Adolescent | 3 | 2000 | 6081 | 0.050 |
Why?
|
| Kinetics | 3 | 1996 | 695 | 0.050 |
Why?
|
| Injections, Intraventricular | 2 | 2005 | 59 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2003 | 29 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2003 | 40 | 0.050 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2003 | 92 | 0.050 |
Why?
|
| Cadmium Poisoning | 1 | 1983 | 2 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 1991 | 1001 | 0.050 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1983 | 8 | 0.050 |
Why?
|
| Exons | 1 | 2003 | 92 | 0.050 |
Why?
|
| Arginine | 1 | 2003 | 75 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2003 | 114 | 0.050 |
Why?
|
| Guanabenz | 1 | 2003 | 3 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 1983 | 73 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2003 | 139 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2003 | 168 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2003 | 128 | 0.050 |
Why?
|
| Biological Transport | 1 | 2003 | 204 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 137 | 0.050 |
Why?
|
| Epitopes | 1 | 2003 | 157 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 2003 | 77 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2004 | 150 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2003 | 111 | 0.050 |
Why?
|
| Protein Binding | 2 | 2003 | 1082 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2003 | 135 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2003 | 149 | 0.050 |
Why?
|
| Benzazepines | 1 | 2003 | 33 | 0.050 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2003 | 110 | 0.050 |
Why?
|
| Sympathetic Nervous System | 1 | 2003 | 57 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2003 | 490 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2003 | 239 | 0.050 |
Why?
|
| Genetic Variation | 2 | 1981 | 430 | 0.050 |
Why?
|
| Diphenylhexatriene | 2 | 1991 | 2 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2003 | 570 | 0.040 |
Why?
|
| Fetus | 4 | 2003 | 101 | 0.040 |
Why?
|
| Luteinizing Hormone | 1 | 2000 | 61 | 0.040 |
Why?
|
| Ruthenium Red | 1 | 2000 | 3 | 0.040 |
Why?
|
| Sequence Tagged Sites | 1 | 2000 | 4 | 0.040 |
Why?
|
| Menopause | 1 | 2000 | 64 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2002 | 206 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 213 | 0.040 |
Why?
|
| Cell Survival | 1 | 2003 | 945 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2000 | 107 | 0.040 |
Why?
|
| Mitochondria | 1 | 2003 | 523 | 0.040 |
Why?
|
| Cytokines | 1 | 2003 | 678 | 0.040 |
Why?
|
| Staurosporine | 3 | 2003 | 38 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1999 | 29 | 0.040 |
Why?
|
| Cloning, Organism | 1 | 1999 | 22 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2002 | 386 | 0.040 |
Why?
|
| Acrodermatitis | 1 | 1979 | 4 | 0.040 |
Why?
|
| Cell Count | 1 | 1999 | 145 | 0.040 |
Why?
|
| Apoptosis | 2 | 2003 | 1568 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 1998 | 68 | 0.040 |
Why?
|
| Spleen | 1 | 1999 | 204 | 0.040 |
Why?
|
| Gene Library | 1 | 1998 | 62 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 138 | 0.040 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1998 | 12 | 0.040 |
Why?
|
| Testis | 1 | 1999 | 207 | 0.030 |
Why?
|
| Electrochemistry | 1 | 1998 | 38 | 0.030 |
Why?
|
| Pregnancy | 5 | 1987 | 1772 | 0.030 |
Why?
|
| Base Sequence | 2 | 1998 | 983 | 0.030 |
Why?
|
| Oxazoles | 1 | 1997 | 19 | 0.030 |
Why?
|
| Young Adult | 1 | 2009 | 5080 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 1999 | 638 | 0.030 |
Why?
|
| o-Phthalaldehyde | 1 | 1997 | 4 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 1995 | 1621 | 0.030 |
Why?
|
| Biperiden | 1 | 1997 | 1 | 0.030 |
Why?
|
| Nortriptyline | 1 | 1997 | 1 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1997 | 61 | 0.030 |
Why?
|
| Maprotiline | 1 | 1997 | 3 | 0.030 |
Why?
|
| Amitriptyline | 1 | 1997 | 9 | 0.030 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1996 | 6 | 0.030 |
Why?
|
| Phencyclidine | 1 | 1996 | 19 | 0.030 |
Why?
|
| Kidney | 1 | 1999 | 372 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 316 | 0.030 |
Why?
|
| Olfactory Bulb | 1 | 1997 | 50 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1997 | 184 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 1997 | 234 | 0.030 |
Why?
|
| Lung | 1 | 1999 | 492 | 0.030 |
Why?
|
| Hypertension | 1 | 2003 | 835 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1997 | 611 | 0.030 |
Why?
|
| Ligands | 2 | 1991 | 388 | 0.030 |
Why?
|
| Cohort Studies | 1 | 1999 | 1759 | 0.030 |
Why?
|
| Dioxanes | 1 | 1993 | 11 | 0.030 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1994 | 28 | 0.030 |
Why?
|
| Premenstrual Syndrome | 1 | 1993 | 13 | 0.030 |
Why?
|
| Culture Media, Serum-Free | 2 | 2003 | 44 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2000 | 2544 | 0.030 |
Why?
|
| Catecholamines | 1 | 1993 | 45 | 0.020 |
Why?
|
| Morpholines | 2 | 2003 | 72 | 0.020 |
Why?
|
| Chromones | 2 | 2003 | 53 | 0.020 |
Why?
|
| Caspases | 2 | 2003 | 148 | 0.020 |
Why?
|
| Caspase 3 | 2 | 2003 | 227 | 0.020 |
Why?
|
| Cell Death | 2 | 2003 | 278 | 0.020 |
Why?
|
| Osmolar Concentration | 2 | 1995 | 52 | 0.020 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1992 | 23 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1992 | 55 | 0.020 |
Why?
|
| Fluorescence Polarization | 1 | 1991 | 28 | 0.020 |
Why?
|
| Fluorescence | 1 | 1991 | 118 | 0.020 |
Why?
|
| Species Specificity | 2 | 1983 | 286 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 1990 | 45 | 0.020 |
Why?
|
| Affect | 1 | 1992 | 180 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1989 | 63 | 0.020 |
Why?
|
| Models, Statistical | 1 | 1990 | 195 | 0.020 |
Why?
|
| Cognition | 1 | 1992 | 473 | 0.020 |
Why?
|
| Animals, Wild | 1 | 1987 | 24 | 0.020 |
Why?
|
| Micelles | 1 | 1987 | 36 | 0.020 |
Why?
|
| Physical Exertion | 1 | 1986 | 27 | 0.020 |
Why?
|
| Models, Biological | 1 | 1990 | 712 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1983 | 126 | 0.020 |
Why?
|
| Cell Separation | 1 | 1986 | 94 | 0.020 |
Why?
|
| Cadmium | 2 | 1983 | 56 | 0.020 |
Why?
|
| Chemistry | 1 | 1986 | 15 | 0.020 |
Why?
|
| Filtration | 1 | 1986 | 17 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1989 | 1081 | 0.010 |
Why?
|
| Glass | 1 | 1986 | 19 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1986 | 56 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1987 | 134 | 0.010 |
Why?
|
| Nifedipine | 1 | 2005 | 10 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1987 | 238 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2005 | 36 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2006 | 92 | 0.010 |
Why?
|
| Naloxone | 1 | 2005 | 56 | 0.010 |
Why?
|
| Gestational Age | 2 | 1983 | 200 | 0.010 |
Why?
|
| Hydrocortisone | 2 | 1983 | 93 | 0.010 |
Why?
|
| Imidazolines | 1 | 2005 | 1 | 0.010 |
Why?
|
| 5,6-Dihydroxytryptamine | 1 | 2005 | 2 | 0.010 |
Why?
|
| Serotonin Agents | 1 | 2005 | 3 | 0.010 |
Why?
|
| Adrenergic Agents | 1 | 2005 | 8 | 0.010 |
Why?
|
| Bradycardia | 1 | 2005 | 9 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2005 | 127 | 0.010 |
Why?
|
| Presynaptic Terminals | 1 | 2005 | 54 | 0.010 |
Why?
|
| Research Design | 1 | 1986 | 385 | 0.010 |
Why?
|
| Serotonin | 1 | 2005 | 123 | 0.010 |
Why?
|
| Ornithine Decarboxylase | 1 | 2004 | 10 | 0.010 |
Why?
|
| DNA Probes | 1 | 2004 | 32 | 0.010 |
Why?
|
| Integrin alpha5beta1 | 1 | 2003 | 6 | 0.010 |
Why?
|
| Dopamine | 1 | 2006 | 275 | 0.010 |
Why?
|
| Calcimycin | 1 | 2003 | 11 | 0.010 |
Why?
|
| Ionophores | 1 | 2003 | 11 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 2003 | 25 | 0.010 |
Why?
|
| Thapsigargin | 1 | 2003 | 7 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2003 | 27 | 0.010 |
Why?
|
| Androstadienes | 1 | 2003 | 19 | 0.010 |
Why?
|
| Anilides | 1 | 2003 | 28 | 0.010 |
Why?
|
| N-Methylaspartate | 1 | 2003 | 59 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 64 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2004 | 272 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 1983 | 23 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1983 | 23 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2003 | 100 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 311 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2003 | 109 | 0.010 |
Why?
|
| Nicotine | 1 | 2006 | 302 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2003 | 131 | 0.010 |
Why?
|
| Flavonoids | 1 | 2003 | 100 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2002 | 8 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 52 | 0.010 |
Why?
|
| Metals | 1 | 1983 | 114 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2003 | 159 | 0.010 |
Why?
|
| Organ Size | 1 | 2002 | 170 | 0.010 |
Why?
|
| Immunoelectrophoresis | 1 | 1981 | 3 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 411 | 0.010 |
Why?
|
| Lactose | 1 | 1981 | 16 | 0.010 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2002 | 23 | 0.010 |
Why?
|
| Trypsin | 1 | 1981 | 40 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1981 | 32 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2003 | 383 | 0.010 |
Why?
|
| Tyrosine | 1 | 2002 | 120 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1981 | 37 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2003 | 306 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1981 | 197 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 244 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 423 | 0.010 |
Why?
|
| Amino Acids | 1 | 1981 | 148 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2002 | 280 | 0.010 |
Why?
|
| Phylogeny | 1 | 2004 | 769 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1981 | 307 | 0.010 |
Why?
|
| Age Factors | 1 | 1982 | 1154 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 986 | 0.010 |
Why?
|
| Milk, Human | 1 | 1979 | 51 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1996 | 283 | 0.010 |
Why?
|
| Luteal Phase | 1 | 1993 | 6 | 0.010 |
Why?
|
| Follicular Phase | 1 | 1993 | 5 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1989 | 159 | 0.000 |
Why?
|
| Genes | 1 | 1983 | 56 | 0.000 |
Why?
|
| Cadmium Chloride | 1 | 1983 | 10 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1983 | 132 | 0.000 |
Why?
|
| DNA | 1 | 1983 | 592 | 0.000 |
Why?
|